Abbott LaboratoriesABTNYSE
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank57
3Y CAGR+6.5%
5Y CAGR-4.9%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
+6.5%/yr
vs -15.2%/yr prior
5Y CAGR
-4.9%/yr
Recent acceleration
Acceleration
+21.7pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 33.55 | +129.6% |
| 2024 | 14.62 | -56.2% |
| 2023 | 33.35 | +20.1% |
| 2022 | 27.76 | -21.4% |
| 2021 | 35.33 | -18.2% |
| 2020 | 43.19 | +3.7% |
| 2019 | 41.65 | -22.3% |
| 2018 | 53.62 | -74.3% |
| 2017 | 208.61 | +416.2% |
| 2016 | 40.41 | - |